|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.79/--
|
企业价值
139.57M
|
资产负债 |
每股账面净值
2.44
|
现金流量 |
现金流量率
--
|
损益表 |
收益
6.00M
|
每股收益
--
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/03 04:28 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |